SIGMAR1 and cancer: Likewise, it is also not yet clear whether “classical” Sig1R agonists and antagonists do exist since several fundamental questions regarding the drug mechanism of action and the physiological relevance of aberrant Sig1R transcript and Sig1R protein expression in certain cancers remain unanswered or only partially answered [33].